Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.1100 (4.6%) ($13.2700 - $14.1800) on Tue. Aug. 13, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 42 | Latest Price | $14.1100(4.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.645% in a week (0% probabilities). VIXM(-35%) VXX(-34%) TLT(-12%) UNG(-7%) IFRA(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 0 () | Intraday Trend | 5.5% | | | |
|
1 - 5 Day Possible Target | $-1.75(-112.4%) | 5 Day Moving Average | $13.1(7.71%) | 10 Day Moving Average | $13.11(7.63%) | 20 Day Moving Average | $13.94(1.22%) | To recent high | -43.5% | To recent low | 17.3% | Market Cap | $1.048b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |